Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination

Hum Gene Ther. 2023 Sep;34(17-18):896-904. doi: 10.1089/hum.2023.123.

Abstract

The development of prophylatic or therapeutic medicines for infectious diseases is one of the priorities for health organizations worldwide. Innovative solutions are required to achieve effective, safe, and accessible treatments for most if not all infectious diseases, particularly those that are chronic in nature or that emerge unexpectedly over time. Genetic technologies offer versatile possibilities to design therapies against pathogens. Recent developments such as mRNA vaccines, CRISPR gene editing, and immunotherapies provide unprecedented hope to achieve significant results in the field of infectious diseases. This review will focus on advances in this domain, showcasing the cross-fertilization with other fields (e.g., oncology), and addressing some of the logistical and economic concerns important to consider when making these advances accessible to diverse populations around the world.

Keywords: gene therapy; immunotherapy; infectious diseases; lipid nanoparticles; mRNA; vaccines.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cloning, Molecular
  • Clustered Regularly Interspaced Short Palindromic Repeats
  • Communicable Diseases* / genetics
  • Communicable Diseases* / therapy
  • Genetic Therapy
  • Humans
  • Vaccination